aid: triveni-bio
name: Triveni Bio
description: 'Triveni Bio is a clinical-stage biotechnology company developing first-in-class
  antibody therapeutics for immunological and inflammatory (I&I) disorders, built on a
  genetics-informed approach to target discovery combined with advanced antibody engineering.
  Its lead program TRIV-509 is a dual-specific monoclonal antibody against kallikreins 5
  and 7 (KLK5/7) for moderate-to-severe atopic dermatitis, addressing barrier dysfunction,
  inflammation and itch; TRIV-573 is a half-life-extended, second-generation bispecific
  that pairs the KLK5/7 mechanism with anti-interleukin-13 (IL-13) and entered Phase 1 in
  2026. The pipeline also includes an antibody inhibitor of trypsin 1 and 2 for hereditary
  pancreatitis driven by PRSS1 mutations. The company launched with a $92M Series A, raised
  a $115M Series B, and closed a $65M Series C in June 2026, and was named a Fierce 15
  biotech of 2025. Triveni Bio is a therapeutics developer, not a software vendor: it
  publishes no public API, developer portal, SDK or machine-readable specification.'
url: https://raw.githubusercontent.com/api-evangelist/triveni-bio/refs/heads/main/apis.yml
image: https://triveni.bio/wp-content/uploads/2025/09/cropped-triveni-icon-1-192x192.png
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.23'
created: '2026-08-05'
modified: '2026-08-05'
tags:
- Company
- Biotechnology
- Life Sciences
- Pharmaceuticals
- Therapeutics
- Antibodies
- Immunology
- Drug Development
- Clinical Trials
- Healthcare
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/triveni-bio-domain-security.yml
- type: Website
  url: https://triveni.bio/
- type: About
  url: https://triveni.bio/about/
- type: Blog
  url: https://triveni.bio/news/
- type: BlogRSS
  url: https://triveni.bio/feed/
- type: PrivacyPolicy
  url: https://triveni.bio/privacy-policy/
- type: TermsOfService
  url: https://triveni.bio/terms-and-conditions/
- type: Careers
  url: https://triveni.bio/about#careers
- type: LinkedIn
  url: https://www.linkedin.com/company/triveni-bio
- type: Contact
  url: https://triveni.bio/contact/
- type: Email
  url: mailto:info@triveni.bio
- type: SecondaryMarket
  url: https://forgeglobal.com/triveni-bio_stock/
- type: LLMsTxt
  url: llms/triveni-bio-llms.txt
x-enrichment:
  date: '2026-08-05'
  status: minimal
  artifacts_added: 2
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: >-
    Triveni Bio is a clinical-stage antibody therapeutics developer whose entire public site
    is seven WordPress pages (home, about, science, pipeline, news, contact, legal) with no
    developer, technology, or partner-integration section at all; every API-host, docs-host
    and /.well-known/ probe 404'd and no api./developer./docs. subdomain resolves.
  evidence:
    - url: https://triveni.bio/page-sitemap.xml
      status: 200
    - url: https://triveni.bio/developers
      status: 404
    - url: https://triveni.bio/openapi.json
      status: 404
    - url: https://triveni.bio/.well-known/agent-card.json
      status: 404
    - url: https://triveni.bio/llms.txt
      status: 404
  checked: '2026-08-05'